Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study

✍ Scribed by Baccarani, Michele; Druker, Brian J.; Branford, Susan; Kim, Dong-Wook; Pane, Fabrizio; Mongay, Lidia; Mone, Manisha; Ortmann, Christine-Elke; Kantarjian, Hagop M.; Radich, Jerald P.; Hughes, Timothy P.; Cortes, Jorge E.; Guilhot, François

• Book ID: 125379014
• Publisher: Carden Jennings Publishing
• Year: 2014
• Tongue: English
• Weight: 340 KB
• Volume: 99
• Category: Article
• ISSN: 0925-5710
• DOI: 10.1007/s12185-014-1566-2